News

Pedigree-pioneering team resurfaces with cloud-based collaborative platform

Agency strives to balance risks and benefits in how drugs are presented in direct-to-consumer (DTC) campaigns

New Apple gadget could help usher in an era of medical applications fully integrated into a healthcare professional’s day-to-day life

Generics are now 75% of dispensed prescriptions, with generics up 5.9% in 2009 and branded products down 7.6%

In latest Harris Interactive study, reputation of the pharmaceutical industry drops, but still fares better than some sectors

Code would include NDC number; GS1 coding structure gets a nod

Growing digitization of patient data could break the threshold to better adherence to medication therapies

AmerisourceBergen Packaging and Pfizer partner to develop a cost-effective starter pack for Toviaz tablets

EFPIA wraps up its 2009 test; a new pilot in the UK with Reckett-Benckiser

The Medical Affairs function can play a vital role in today’s product launch process

Over half of all physicians are participating in social-media sites or online professional networks

How the many anticounterfeiting measures on the market today could turn into a means of connecting with patients

Class-wide opioid REMS will affect four million patients and require cooperation of more than 25 drug manufacturers

More and more parts of the healthcare industry are connecting

Preparing for the effects of economic recovery on a changed logistics landscape is the theme

Company partners with R-Squared to provide collect and qualify promotional spending data

‘Dear Doctor’ notification network evolves into a leading provider of REMS program information

IT developer promotes concept of 'revenue management life cycle'

Old software and poor data quality cause both revenue losses and extra expense to reconcile claims. Will serialized packages provide an eventual cure?

While researchers study new pain-killing pathways, the pharma industry tries drug combinations and alternative-delivery mechanisms By Angelo DePalma, PhD

Shared-risk or ‘pay for performance’ agreements between drugmakers and payers can represent uncertain rewards for both parties. Use strategic planning before entering into them

Kaiser Permanente files a citizen’s petition to revise FDA’s process of imposing REMS programs, also objects to restrictions on wholesale-distribution